HealthStream, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HSTM research report →
Range $27 – $27
Price Chart
About the company
HealthStream, Inc. , established in 1990 and headquartered in Nashville, Tennessee, delivers specialized workforce and provider solutions to healthcare organizations throughout the United States. Its operations are divided into two primary segments: Workforce Solutions and Provider Solutions.
- CEO
- Robert A. Frist Jr.
- IPO
- 2000
- Employees
- 1,150
- HQ
- Nashville, TN, US
Get TickerSpark's AI analysis on HSTM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $804.37M
- P/E
- 39.49
- Fwd P/E
- 35.37
- PEG
- 13.43
- P/S
- 2.56
- P/B
- 2.02
- EV/EBITDA
- 11.19
- Div Yield
- 0.51%
- Gross Margin
- 64.74%
- Op Margin
- 7.57%
- Net Margin
- 6.25%
- ROE
- 5.60%
- ROIC
- 4.33%
Latest fiscal year · YoY change
- Revenue
- $304.06M+4.3%
- Gross Profit
- $196.85M+1.6%
- Op Income
- $20.24M
- Net Income
- $18.34M-8.3%
- EPS
- $0.61-7.6%
- OCF Growth
- +9.8%
- FCF Growth
- +102.0%
- 52W High
- $35.61
- 52W Low
- $19.50
- 50D MA
- $30.97
- 200D MA
- $26.11
- Beta
- 0.43
- RSI (14)
- 25
- Avg Volume
- 217.93K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
HealthStream raised full-year guidance after an 8.9% revenue increase in Q3, with management highlighting growing suite adoption, strong cash generation, and a more aggressive product/platform strategy.· November 3, 2026
- Q3 revenue was $83.3 million, up 8.9% year over year; adjusted EBITDA was $19.3 million with a 23.2% margin.
- Full-year guidance was raised to revenue of $331 million-$333 million, net income of $21.8 million-$22.4 million, and adjusted EBITDA of $77 million-$78 million.
- Subscription growth remained the main driver, with organic revenue growth of 4.7%; CredentialStream grew 15%, ShiftWizard 20%, Resuscitation Suite 14%, Competency products 10%, and myClinicalExchange 34%.
- Management said customers are increasingly buying broad suites and bundles instead of point solutions, which it expects to support larger contracts and renewal strength.
- The company ended Q3 with $115.2 million in cash and marketable securities, no debt, and a newly extended $50 million credit facility, after raising about $40 million in a private placement.
Q3 2026 revenue was $83.3 million, up 8.9% from $76.5 million a year ago. Operating income was $6.6 million, down 13%; net income was $5.4 million, down 11.7%; EPS was $0.18 versus $0.20 last year; and adjusted EBITDA was $19.3 million, up 1%, with a 23.2% margin versus 25.0% last year. Gross margin was 64.0% versus 65.3% in the prior-year quarter, reflecting higher labor, software, royalty, and hosting costs. For the first nine months, revenue rose 10.6% to $248.2 million and adjusted EBITDA rose 13.4% to $60 million. Full-year 2026 guidance was raised to revenue of $331 million-$333 million, net income of $21.8 million-$22.4 million, adjusted EBITDA of $77 million-$78 million, and capital expenditures of $31 million-$34 million. Management said Q4 revenue growth should be 4%-6% and Q4 adjusted EBITDA margin should approximate 21%.
CEO Bobby Frist framed the quarter as evidence that HealthStream’s platform strategy is gaining traction, especially around programmatic suites, market bundles, and career networks. He repeatedly emphasized that customers want integrated solutions, vendor consolidation, and a single verified clinician record powering more complete workflows across competency, compliance, and resuscitation. His tone was confident and expansionary, particularly on AI, the hStream platform, and the idea that HealthStream is becoming a broader platform-as-a-service ecosystem rather than a collection of point products.
CFO Scotty Roberts focused on the financial performance, balance sheet, and guidance implications. He cited $83.3 million in revenue, 64.0% gross margin, $19.3 million in adjusted EBITDA, $115.2 million in cash and investments, no funded debt, and positive free cash flow; year to date, operating cash flow was $58 million and free cash flow was $34.7 million. He also highlighted the $40 million private placement, the extended $50 million credit facility, a quarterly dividend of $0.035 per share, and about $9.3 million of share repurchases during the first nine months of the year. On margins, he said the AWS hosting migration should create some margin pressure over several quarters, but should be better longer term.
Analysts pressed on whether the suite/bundle strategy could slow sales cycles, and management said the dynamics cut both ways: larger deals may take more approvals, but the economics and vendor-consolidation message are resonating and pipeline timing has not clearly slowed. Several questions focused on margins and the AWS migration; management said the transition will take several quarters through 2027 and may cause temporary pressure, but should improve security, efficiency, and unit economics over time. Analysts also asked about legacy and sunsetting products, and management said that bucket now represents less than 10% of revenue and that they plan to be more aggressive about moving customers off older products. On the capital raise, Frist said the new shareholder came through an investment linked to Impact Vitality and wanted exposure to both companies.
The call presented a business with accelerating revenue, raised guidance, and clear operating leverage potential from higher-value suites and bundles. Management sees strong customer pull for integrated solutions, and they believe the platform, data, and AI advantages become more valuable as more clinicians and applications are connected. Cash generation, no debt, and a sizable cash balance also give the company room to invest, buy back stock, pay dividends, and pursue acquisitions.
Gross margin fell to 64.0% from 65.3%, and management expects some additional short-term pressure from the AWS migration and higher Q4 trade show and labor spending. Revenue from legacy and sunsetting products declined, and management said those products will not be growth drivers and may be managed more aggressively over time. Frist also acknowledged that newer areas like Virsys12, MissionCare, and large payer opportunities are only performing 'okay' so far and are not yet meeting higher expectations.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 71.6%
- Shares Outstanding
- 30.60M
- Float Shares
- 21.91M
of shares held by institutions
220 13F filers
Buy/sell ratio 0.39. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for HSTM, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Greg GianforteHouse · MT00 | Sell | Jun 7, 18 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 4.08M | ▲ 228.22K |
| Vanguard Group Inc | 2.54M | ▼ 448.18K |
| Dimensional Fund Advisors LP | 1.62M | ▲ 59.65K |
| Copeland Capital Management, LLC | 1.22M | ▼ 31.15K |
| Vanguard Capital Management LLC | 1.05M | ▼ 2.63K |
| State Street Corp | 1.02M | ▲ 11.99K |
| Vanguard Portfolio Management LLC | 880.54K | ▼ 41.30K |
| Geode Capital Management, LLC | 865.36K | ▲ 86.14K |
| Two Sigma Investments, LP | 805.58K | ▼ 38.84K |
| Acadian Asset Management LLC | 775.54K | ▲ 203.72K |
| Goldman Sachs Group Inc | 665.92K | ▲ 391.46K |
| First Eagle Investment Management, LLC | 636.45K | ▲ 44.55K |
Held by 298 ETFs
Biggest fund positions in HSTM by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 6, 26 | Taylor Tate Deborah | other | 900 |
| Nov 5, 26 | O'Hara Kevin P | sell | 4,000 |
| Nov 5, 26 | Taylor Tate Deborah | sell | 3,281 |
| Nov 5, 26 | Roberts Scott Alexander | sell | 9,500 |
| Nov 5, 26 | Collier Michael Manning | other | 18,000 |
| Nov 5, 26 | Collier Michael Manning | sell | 3,300 |
| Nov 5, 26 | Collier Michael Manning | sell | 18,000 |
| Nov 5, 26 | Collier Michael Manning | other | 18,000 |
| Oct 29, 26 | Coady Trisha L | other | 2,995 |
| Oct 29, 26 | Coady Trisha L | other | 730 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HSTM coverage
Recent articles, reports, and earnings notes.
No research on HSTM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HSTM report →Buy Internet Service Players Sprout Social and HealthStream
zacks.com · Nov 17
Down 16.9% in 4 Weeks, Here's Why HealthStream (HSTM) Looks Ripe for a Turnaround
zacks.com · Nov 17
HealthStream (HSTM) Upgraded to Buy: Here's What You Should Know
zacks.com · Nov 6
DarioHealth (NASDAQ:DRIO) and HealthStream (NASDAQ:HSTM) Critical Survey
defenseworld.net · Nov 6
HealthStream, Inc. (HSTM) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 3
What HealthStream (HSTM) Said on Its Q3 Earnings Call
marketbeat.com · Nov 3
HealthStream (HSTM) Q3 Earnings and Revenues Surpass Estimates
zacks.com · Nov 2
HealthStream Announces Third Quarter 2026 Results
businesswire.com · Nov 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.